title: Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke.
abstract: CONCLUSIONS
  Glutamate serves multi-faceted (patho)physiological functions in the central nervous system as the most abundant excitatory neurotransmitter and under pathological conditions as a potent neurotoxin. Regarding the latter, elevated extracellular glutamate is known to play a central role in ischemic stroke brain injury.
  
  
  BACKGROUND
  Glutamate oxaloacetate transaminase (GOT) has emerged as a new therapeutic target in protecting against ischemic stroke injury. Oxygen-sensitive induction of GOT expression and activity during ischemic stroke lowers glutamate levels at the stroke site while sustaining adenosine triphosphate levels in brain. The energy demands of the brain are among the highest of all organs underscoring the need to quickly mobilize alternative carbon skeletons for metabolism in the absence of glucose during ischemic stroke. Recent work builds on the important observation of Hans Krebs that GOT-mediated metabolism of glutamate generates tri-carboxylic acid (TCA) cycle intermediates in brain tissue. Taken together, outcomes suggest GOT may enable the transformative switch of otherwise excitotoxic glutamate into life-sustaining TCA cycle intermediates during ischemic stroke.
  
  
  RESULTS
  Neuroprotective strategies that focus solely on blocking mechanisms of glutamate-mediated excitotoxicity have historically failed in clinical trials. That GOT can enable glutamate to assume the role of a survival factor represents a paradigm shift necessary to develop the overall significance of glutamate in stroke biology.
  
  
  CONCLUSIONS
  Ongoing efforts are focused to develop the therapeutic significance of GOT in stroke-affected brain. Small molecules that target induction of GOT expression and activity in the ischemic penumbra are the focus of ongoing studies.
authors.affiliation: Department of Surgery, The Ohio State University Wexner Medical Center , Columbus, Ohio.
authors.forename: Savita
authors.initials: S
authors.lastname: Khanna
authors.forename: Zachary
authors.initials: Z
authors.lastname: Briggs
authors.forename: Cameron
authors.initials: C
authors.lastname: Rink
mesh_terms: D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism*; D002952:Citric Acid Cycle / Q000502:physiology; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D020521:Stroke / Q000201:enzymology*
chemical_list: D018698:Glutamic Acid; D001219:Aspartate Aminotransferases